Novo Nordisk's pricing tactics in the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who's got accused the company of price gouging, stating the stark contrast between U.S. rates and people in Europe and copyright.In October 2024, Novo Nordisk revealed a review on scientific journal Character a few novel glucose-delicate insul